Sipoglitazar
Catalog No. A22625
Sipoglitazar, also known as TAK-654, is a PPARγ agonist potentially for the treatment of diabetes.
| Catalog Num | A22625 |
|---|---|
| M. Wt | 463.55 |
| Formula | C25H25N3O4S |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 342026-92-0 |
| Synonyms | TAK-654; TAK 654; TAK654 |
| SMILES | O=C(O)CCC1=CN(CC2=CC=C(OCC3=CSC(C4=CC=CC=C4)=N3)C=C2)N=C1OCC |
Sipoglitazar, also known as TAK-654, is a PPARγ agonist potentially for the treatment of diabetes.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 21.57 mL | 107.86 mL | 215.73 mL |
| 0.5 mM | 4.31 mL | 21.57 mL | 43.15 mL |
| 1 mM | 2.16 mL | 10.79 mL | 21.57 mL |
| 5 mM | 0.43 mL | 2.16 mL | 4.31 mL |
*The above data is based on the productmolecular weight 463.55. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.